Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 2/2009

01.02.2009 | ORIGINAL PAPER

Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency

verfasst von: Jacqueline Hoeppner, Lara Prudente-Morrissey, Sabine Christiane Herpertz, Reiner Benecke, Uwe Walter

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Substantia nigra hyperechogenicity (SNH) is a characteristic transcranial sonography (TCS) finding in Parkinson’s disease (PD). SNH, found also in about 10% of healthy adults, was related to a subclinical malfunction of the nigrostriatal dopaminergic system on positron emission tomography studies. Both, liability for developing PD and frequency of SNH were found to be increased in depressed subjects. Here, we investigated whether SNH in depression is related to motor or cognitive abnormalities resembling early PD.

Methods

Fourty-one patients with major depressive disorder and 15 with adjustment disorder with depressed mood were studied clinically and with TCS.

Results

Frequency of SNH was similar in both groups (39, 33%; Chi-square test, P = 0.70). Larger SN echogenic size correlated with larger right-to-left asymmetry of finger tapping (Spearman test, r = 0.37, P = 0.009) and lower verbal fluency (r = −0.35, P = 0.038). These correlations were stronger in patients at ages ≥ 50 years (r = 0.52, P = 0.007; r = −0.50, P = 0.020), and, independently from age, in patients with reduced echogenicity of brainstem raphe suggested to reflect alteration of the serotonergic system (r = 0.40, P = 0.045; r = −0.51, P = 0.044). Whereas bilateral sum score of finger tapping was negatively correlated with severity of depression on the beck depression inventory (r = −0.50, P = 0.001) and the Hamilton depression rating scale (r = −0.34, P = 0.019), no correlation was found between depression severity and tapping asymmetry, or between depression severity and verbal fluency.

Conclusion

Data suggest that TCS detects a subgroup of patients with depression characterized by symptoms of early parkinsonism who are possibly at an elevated risk of later developing definite PD.
Literatur
1.
Zurück zum Zitat Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA (2005) Modulation of dopamine release by striatal 5-HT2C receptors. Synapse 55:242–251PubMedCrossRef Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA (2005) Modulation of dopamine release by striatal 5-HT2C receptors. Synapse 55:242–251PubMedCrossRef
2.
Zurück zum Zitat American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. American Psychiatric Press, Washington DC American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. American Psychiatric Press, Washington DC
3.
Zurück zum Zitat Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMed Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMed
4.
Zurück zum Zitat Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K (1995) Degeneration of substantia nigra in chronic Parkinson’s disease visualized by transcranial color-coded real-time sonography. Neurology 45:182–184PubMed Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K (1995) Degeneration of substantia nigra in chronic Parkinson’s disease visualized by transcranial color-coded real-time sonography. Neurology 45:182–184PubMed
5.
Zurück zum Zitat Becker G, Becker T, Struck M, Lindner A, Burzer K, Retz W, Bogdahn U, Beckmann H (1995) Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study. Biol Psychiatry 38:180–184PubMedCrossRef Becker G, Becker T, Struck M, Lindner A, Burzer K, Retz W, Bogdahn U, Beckmann H (1995) Reduced echogenicity of brainstem raphe specific to unipolar depression: a transcranial color-coded real-time sonography study. Biol Psychiatry 38:180–184PubMedCrossRef
6.
Zurück zum Zitat Becker G, Berg D, Lesch KP, Becker T (2001) Basal limbic system alteration in major depression: a hypothesis supported by transcranial sonography and MRI findings. Int J Neuropsychopharmacol 4:21–31PubMedCrossRef Becker G, Berg D, Lesch KP, Becker T (2001) Basal limbic system alteration in major depression: a hypothesis supported by transcranial sonography and MRI findings. Int J Neuropsychopharmacol 4:21–31PubMedCrossRef
7.
Zurück zum Zitat Berg D, Becker G, Zeiler B, Tucha O, Hofmann E, Preier M, Benz P, Jost W, Reiners K, Lange KW (1999) Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53:1026–1031PubMed Berg D, Becker G, Zeiler B, Tucha O, Hofmann E, Preier M, Benz P, Jost W, Reiners K, Lange KW (1999) Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53:1026–1031PubMed
8.
Zurück zum Zitat Berg D, Jabs B, Merschdorf U, Beckmann H, Becker G (2001) Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 50:463–467PubMedCrossRef Berg D, Jabs B, Merschdorf U, Beckmann H, Becker G (2001) Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy. Biol Psychiatry 50:463–467PubMedCrossRef
9.
Zurück zum Zitat Berg D, Siefker C, Ruprecht-Dörfler P, Becker G (2001) Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 56:13–17PubMedCrossRef Berg D, Siefker C, Ruprecht-Dörfler P, Becker G (2001) Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology 56:13–17PubMedCrossRef
10.
Zurück zum Zitat Berg D, Roggendorf W, Schröder U, Klein R, Tatschner T, Benz P, Tucha O, Preier M, Lange KW, Reiners K, Gerlach M, Becker G (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 56:999–1005CrossRef Berg D, Roggendorf W, Schröder U, Klein R, Tatschner T, Benz P, Tucha O, Preier M, Lange KW, Reiners K, Gerlach M, Becker G (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 56:999–1005CrossRef
11.
Zurück zum Zitat Berg D, Merz B, Reiners K, Naumann M, Becker G (2005) Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson’s disease. Mov Disord 20:383–385PubMedCrossRef Berg D, Merz B, Reiners K, Naumann M, Becker G (2005) Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson’s disease. Mov Disord 20:383–385PubMedCrossRef
12.
Zurück zum Zitat Brandt-Christensen M, Kvist K, Nilsson FM, Andersen PK, Kessing LV (2006) Treatment with antidepressants and lithium is associated with increased risk of treatment with antiparkinson drugs: a pharmacoepidemiological study. J Neurol Neurosurg Psychiatry 77:781–783PubMedCrossRef Brandt-Christensen M, Kvist K, Nilsson FM, Andersen PK, Kessing LV (2006) Treatment with antidepressants and lithium is associated with increased risk of treatment with antiparkinson drugs: a pharmacoepidemiological study. J Neurol Neurosurg Psychiatry 77:781–783PubMedCrossRef
13.
14.
Zurück zum Zitat Camicioli R, Grossmann SJ, Spencer PS, Hudnell K, Anger WK (2001) Discriminating mild parkinsonism: methods for epidemiological research. Mov Disord 16:33–40PubMedCrossRef Camicioli R, Grossmann SJ, Spencer PS, Hudnell K, Anger WK (2001) Discriminating mild parkinsonism: methods for epidemiological research. Mov Disord 16:33–40PubMedCrossRef
15.
Zurück zum Zitat Dujardin K, Duhamel A, Becquet E, Grunberg C, Defebvre L, Destee A (1999) Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson’s disease. J Neurol Neurosurg Psychiatry 67:323–328PubMedCrossRef Dujardin K, Duhamel A, Becquet E, Grunberg C, Defebvre L, Destee A (1999) Neuropsychological abnormalities in first degree relatives of patients with familial Parkinson’s disease. J Neurol Neurosurg Psychiatry 67:323–328PubMedCrossRef
16.
Zurück zum Zitat Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinsońs disease II. Macmillan, New York, pp 153–163 Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinsońs disease II. Macmillan, New York, pp 153–163
17.
Zurück zum Zitat First MB, Spitzer RL, Gibbon M, Williams JBW (1996) Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV). American Psychiatric Press, Washington DC First MB, Spitzer RL, Gibbon M, Williams JBW (1996) Structured clinical interview for DSM-IV axis I disorders, clinician version (SCID-CV). American Psychiatric Press, Washington DC
18.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef
19.
Zurück zum Zitat Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278–296PubMed Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278–296PubMed
20.
Zurück zum Zitat Jahanshahi M, Ardouin CM, Brown RG, Rothwell JC, Obeso J, Albanese A, Rodriguez-Oroz MC, Moro E, Benabid AL, Pollak P, Limousin-Dowsey P (2000) The impact of deep brain stimulation on executive function in Parkinson’s disease. Brain 123:1142–1154PubMedCrossRef Jahanshahi M, Ardouin CM, Brown RG, Rothwell JC, Obeso J, Albanese A, Rodriguez-Oroz MC, Moro E, Benabid AL, Pollak P, Limousin-Dowsey P (2000) The impact of deep brain stimulation on executive function in Parkinson’s disease. Brain 123:1142–1154PubMedCrossRef
21.
Zurück zum Zitat Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR (2003) Higher incidence of depression preceding the onset of Parkinson’s disease: a register study. Mov Disord 18:414–418PubMedCrossRef Leentjens AF, Van den Akker M, Metsemakers JF, Lousberg R, Verhey FR (2003) Higher incidence of depression preceding the onset of Parkinson’s disease: a register study. Mov Disord 18:414–418PubMedCrossRef
22.
Zurück zum Zitat Lees AJ, Smith E (1983) Cognitive deficits in the early stages of Parkinson’s disease. Brain 106:257–270PubMedCrossRef Lees AJ, Smith E (1983) Cognitive deficits in the early stages of Parkinson’s disease. Brain 106:257–270PubMedCrossRef
23.
24.
Zurück zum Zitat Lemke MR, Koethe NH, Schleidt M (2000) Segmentation of behavior and time structure of movements in depressed patients. Psychopathology 33:131–136PubMedCrossRef Lemke MR, Koethe NH, Schleidt M (2000) Segmentation of behavior and time structure of movements in depressed patients. Psychopathology 33:131–136PubMedCrossRef
25.
Zurück zum Zitat Lezak MD (1995) Neuropsychological assessment. Oxford University Press, New York Lezak MD (1995) Neuropsychological assessment. Oxford University Press, New York
26.
Zurück zum Zitat Nilsson FM, Kessing LV, Bolwig TG (2001) Increased risk of developing Parkinson’s disease for patients with major affective disorder: a register study. Acta Psychiatr Scand 104:380–386PubMedCrossRef Nilsson FM, Kessing LV, Bolwig TG (2001) Increased risk of developing Parkinson’s disease for patients with major affective disorder: a register study. Acta Psychiatr Scand 104:380–386PubMedCrossRef
27.
Zurück zum Zitat Reitan RM (1985) Validity of the trail making test as an indication of organic brain damage. Percept Mot Skills 8:271–276CrossRef Reitan RM (1985) Validity of the trail making test as an indication of organic brain damage. Percept Mot Skills 8:271–276CrossRef
28.
Zurück zum Zitat Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97–113PubMedCrossRef Oldfield RC (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9:97–113PubMedCrossRef
29.
Zurück zum Zitat Ruprecht-Dorfler P, Klotz P, Becker G, Berg D (2007) Substantia nigra hyperechogenicity correlates with subtle motor dysfunction in tap dancers. Parkinsonism Relat Disord 13:362–364PubMedCrossRef Ruprecht-Dorfler P, Klotz P, Becker G, Berg D (2007) Substantia nigra hyperechogenicity correlates with subtle motor dysfunction in tap dancers. Parkinsonism Relat Disord 13:362–364PubMedCrossRef
30.
Zurück zum Zitat Schuurman AG, van den Akker M, Ensinck KT, Metsemakers JF, Knottnerus JA, Leentjens AF, Buntinx F (2002) Increased risk of Parkinson’s disease after depression: a retrospective cohort study. Neurology 58:1501–1504PubMed Schuurman AG, van den Akker M, Ensinck KT, Metsemakers JF, Knottnerus JA, Leentjens AF, Buntinx F (2002) Increased risk of Parkinson’s disease after depression: a retrospective cohort study. Neurology 58:1501–1504PubMed
31.
Zurück zum Zitat Shiba M, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA (2000) Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case-control study. Mov Disord 15:669–677PubMedCrossRef Shiba M, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA (2000) Anxiety disorders and depressive disorders preceding Parkinson’s disease: a case-control study. Mov Disord 15:669–677PubMedCrossRef
32.
Zurück zum Zitat Sobin C, Mayer L, Endicott J (1998) The motor agitation and retardation scale: a scale for the assessment of motor abnormalities in depressed patients. J Neuropsychiatry Clin Neurosci 10:85–92PubMed Sobin C, Mayer L, Endicott J (1998) The motor agitation and retardation scale: a scale for the assessment of motor abnormalities in depressed patients. J Neuropsychiatry Clin Neurosci 10:85–92PubMed
33.
Zurück zum Zitat Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J, Reichmann H (2004) Detection of presymptomatic Parkinson’s disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 19:1196–1202PubMedCrossRef Sommer U, Hummel T, Cormann K, Mueller A, Frasnelli J, Kropp J, Reichmann H (2004) Detection of presymptomatic Parkinson’s disease: combining smell tests, transcranial sonography, and SPECT. Mov Disord 19:1196–1202PubMedCrossRef
34.
Zurück zum Zitat Uc EY, Rizzo M, Anderson SW, Qian S, Rodnitzky RL, Dawson JD (2005) Visual dysfunction in Parkinson disease without dementia. Neurology 65:1907–1913PubMedCrossRef Uc EY, Rizzo M, Anderson SW, Qian S, Rodnitzky RL, Dawson JD (2005) Visual dysfunction in Parkinson disease without dementia. Neurology 65:1907–1913PubMedCrossRef
36.
Zurück zum Zitat Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D (2003) Brain parenchyma sonography discriminates Parkinson’s disease and atypical parkinsonian syndromes. Neurology 60:74–77PubMedCrossRef Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D (2003) Brain parenchyma sonography discriminates Parkinson’s disease and atypical parkinsonian syndromes. Neurology 60:74–77PubMedCrossRef
37.
Zurück zum Zitat Walter U, Klein C, Hilker R, Benecke R, Pramstaller PP, Dressler D (2004) Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 19:1445–1449PubMedCrossRef Walter U, Klein C, Hilker R, Benecke R, Pramstaller PP, Dressler D (2004) Brain parenchyma sonography detects preclinical parkinsonism. Mov Disord 19:1445–1449PubMedCrossRef
38.
Zurück zum Zitat Walter U, Dressler D, Wolters A, Wittstock M, Benecke R (2007) Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson’s disease. Mov Disord 22:48–54PubMedCrossRef Walter U, Dressler D, Wolters A, Wittstock M, Benecke R (2007) Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson’s disease. Mov Disord 22:48–54PubMedCrossRef
39.
Zurück zum Zitat Walter U, Hoeppner J, Prudente-Morrissey L, Horowski S, Herpertz SC, Benecke R (2007) Parkinson’s disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 130:1799–1807PubMedCrossRef Walter U, Hoeppner J, Prudente-Morrissey L, Horowski S, Herpertz SC, Benecke R (2007) Parkinson’s disease-like midbrain sonography abnormalities are frequent in depressive disorders. Brain 130:1799–1807PubMedCrossRef
40.
Zurück zum Zitat Walter U, Prudente-Morrissey L, Herpertz SC, Benecke R, Hoeppner J (2007) Relationship of brainstem raphe echogenicity and clinical findings in depressive states. Psychiatry Res 155:67–73PubMedCrossRef Walter U, Prudente-Morrissey L, Herpertz SC, Benecke R, Hoeppner J (2007) Relationship of brainstem raphe echogenicity and clinical findings in depressive states. Psychiatry Res 155:67–73PubMedCrossRef
Metadaten
Titel
Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency
verfasst von
Jacqueline Hoeppner
Lara Prudente-Morrissey
Sabine Christiane Herpertz
Reiner Benecke
Uwe Walter
Publikationsdatum
01.02.2009
Verlag
Steinkopff-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 2/2009
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-008-0840-9

Weitere Artikel der Ausgabe 2/2009

European Archives of Psychiatry and Clinical Neuroscience 2/2009 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.